Weather Advisory: Temporary Door Closure

Due to extreme cold, access through the Moakley Building's entrance off Boston Medical Center Place will be temporarily closed from 4 p.m. Friday, Feb. 6, through 7 a.m. Monday, Feb. 9.

All patients and visitors should use the main entrance for the Menino and Yawkey Buildings during this time. The hospital remains open and operating as normal.

We appreciate your patience as we take these precautions during severe winter weather.

A stem cell transplant is a treatment used for many diseases where high-dose chemotherapy (with or without radiation) is given to eliminate diseased or abnormal cells, followed by infusion of healthy stem cells that travel to the bone marrow and restore normal blood cell production.

The BMC Stem Cell Transplantation Program provides high-quality, compassionate care to adults with blood cancer, specializing in autologous stem cell transplantation.  

Our program is accredited by the Foundation for the Accreditation of Cellular Therapy (FACT) and is recognized as a Center of Excellence by major health plans, reflecting our commitment to the highest national and international standards for patient safety, quality, and clinical excellence.  

Frequently Asked Questions About Stem Cell Transplants

Conditions We Treat

A disease where amyloid, a type of protein, damages organs and tissues
Cancer that forms in a type of white blood cell called a plasma cell

Our Team

Members of our team also include:

  • Brittany Fuller, senior program manager and clinical quality manager
  • David Benson, project coordinator
  • Marissa Tuler, project coordinator

We collaborate closely with experts in infectious diseases, intensive care, radiation oncology, pathology, behavioral health, and palliative care to ensure comprehensive, coordinated care throughout treatment.